我要投票 葵花SUNFLOWER在医疗保健行业中的票数:250
· 外 推 电 报 ·
2025-02-06 04:33:26 星期四

【葵花SUNFLOWER是哪个国家的品牌?】

葵花SUNFLOWER是什么牌子?「葵花SUNFLOWER」是 葵花药业集团股份有限公司 旗下著名品牌。该品牌发源于黑龙江哈尔滨市,由创始人关玉秀在2005-09-07期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

黑龙江葵花药业集团有限公司,黑龙江名牌,以胃康灵为代表的胃肠用药和小儿肺热咳喘口服液为代表的儿童用药著称


葵花药业集团是以中成药为主,以化学药、生物药、补益保健类产品为辅,集药品制造、营销、科研于一体的大型民营医药企业集团。现拥有五常葵花、伊春葵花、佳木斯葵花、佳木斯(鹿灵)葵花、唐山葵花、衡水葵花、冀州葵花、重庆葵花、隆中葵花、武当葵花、临江葵花、贵州葵花等12家药品生产企业,4家医药公司,1个药物研究院,1个药材种植基地,1个药品包材公司等23家子公司。2014年,在深圳证券交易所成功上市(股票代码:002737)。

在产品布局上,由改制初期的一个产品打天下,现发展为拥有15个剂型、1132个药品批准文号,其中,有29个品种、566个医保目录品种、274个基本药物品种,形成了儿科、妇科、消化系统、呼吸感冒、风湿骨伤病和心脑血管慢病6大特色产品集群,完成了从品种到品牌、再到品类的转化。

在科技研发上,葵花曾成功研发出以护肝片、胃康灵胶囊为代表的全国知名中药产品,为我国中药事业的发展做出了突出贡献。现在北京和哈尔滨分别设立了药物研究院,在各企业均设立了科研所,专注于中药、天然药物、化药的研究开发,通过“买、改、联、研”的研发战略,来不断提高企业创新发展能力。


英文翻译:Heilongjiang sunflower Pharmaceutical Group Co., Ltd., a famous brand in Heilongjiang Province, is famous for gastrointestinal medicine represented by Weikangling and children's lung heat cough and asthma oral liquid. Sunflower Pharmaceutical Group is a large-scale private pharmaceutical enterprise group mainly composed of proprietary Chinese medicine, supplemented by chemical medicine, biological medicine, tonic and health care products, integrating drug manufacturing, marketing and scientific research. Now it has 12 pharmaceutical manufacturers, 4 pharmaceutical companies, 1 Pharmaceutical Research Institute, 1 pharmaceutical planting base, 1 pharmaceutical packaging company and 23 subsidiaries, including Wuchang sunflower, Yichun sunflower, Jiamusi sunflower, Jiamusi (Luling) sunflower, Tangshan sunflower, Hengshui sunflower, Jizhou sunflower, Chongqing sunflower, Longzhong sunflower, Wudang sunflower, Linjiang sunflower and Guizhou sunflower. In 2014, it was successfully listed on Shenzhen Stock Exchange (Stock Code: 002737). In terms of product layout, it has developed from a product in the early stage of restructuring to a product with 15 dosage forms and 1132 drug approval numbers, including 29 varieties, 566 medical insurance catalog varieties and 274 basic drug varieties, forming 6 characteristic product clusters of Pediatrics, gynecology, digestive system, respiratory, rheumatism and osteopathy, and chronic cardiovascular and cerebrovascular diseases, completing the transformation from varieties to brands , and then to category transformation. In terms of scientific and technological research and development, sunflower has successfully developed national famous traditional Chinese medicine products represented by Hugan tablet and Weikangling capsule, which has made outstanding contributions to the development of traditional Chinese medicine in China. Now, Beijing and Harbin have set up drug research institutes respectively, and scientific research institutes have been set up in all enterprises, focusing on the research and development of traditional Chinese medicine, natural medicine and chemical medicine. Through the R & D strategy of "purchase, reform, joint research and development", the innovation and development ability of enterprises has been continuously improved.

本文链接: https://www.waitui.com/brand/49cab8429.html 联系电话:045187690550

千城特选小程序码

7×24h 快讯

美股大型科技股盘前多数下跌,谷歌跌超7%

36氪获悉,美股大型科技股盘前多数下跌,截至发稿,谷歌跌超7%,亚马逊、苹果跌超1%,特斯拉跌0.92%,微软跌0.36%,Meta跌0.35%,奈飞跌0.14%;英伟达涨近1%。

34分钟前

热门中概股美股盘前多数走弱,拼多多跌超7%

36氪获悉,热门中概股美股盘前多数走弱,截至发稿,拼多多跌超7%,理想汽车、微博跌超3%,阿里巴巴、京东、百度、蔚来跌超2%,小鹏汽车、爱奇艺跌超1%;B站涨超1%。

34分钟前

君实生物:AWT020注射用无菌粉末临床试验申请获批

36氪获悉,君实生物公告,近日,公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,AWT020注射用无菌粉末(项目代号“JS213”)的临床试验申请获得批准。JS213是PD-1和白细胞介素-2双功能性抗体融合蛋白,主要用于晚期恶性肿瘤的治疗。

34分钟前

渣打集团任命Maria Ramos接替韦浩思担任集团主席

2月4日,渣打集团董事会宣布,鉴于韦浩思(José Viñals)已接近他服务满9年的任期,已任命Maria Ramos(65岁)接替韦浩思担任集团主席。待取得监管批准后,Maria将于公司在2025年5月8日举行的2025年股东周年大会后履新,而韦浩思届时将自董事会退任。(界面)

34分钟前

三六零:公司暂未向DeepSeek提供任何服务

36氪获悉,三六零公告,公司股票于2025年1月24日、1月27日、2月5日连续三个交易日内收盘价格涨幅偏离值累计超过20%,属于股票交易异常波动情形。经自查,公司注意到相关平台将公司股票纳入DeepSeek概念股。公司就相关事项澄清说明如下:在DeepSeek基于MIT开源协议的生态环境下,公司旗下的部分产品进行了DeepSeek的接入与本地化部署;公司暂未向DeepSeek提供任何服务。除上述事项外,公司未发现其他可能对公司股票交易价格产生较大影响的、需要公司澄清或回应的媒体报道或市场传闻

34分钟前

本页详细列出关于神奇的品牌信息,含品牌所属公司介绍,神奇所处行业的品牌地位及优势。
咨询